Mrs Kelli A Mahaffey, MS CCC-SLP | |
225w 5th St, Crowley, LA 70526-4332 | |
(337) 788-2300 | |
(888) 214-8710 |
Full Name | Mrs Kelli A Mahaffey |
---|---|
Gender | Female |
Speciality | Qualified Speech Language Pathologist |
Experience | 17 Years |
Location | 225w 5th St, Crowley, Louisiana |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1861668741 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | 104028 (Texas) | Secondary |
235Z00000X | Speech-language Pathologist | 6222 (Louisiana) | Primary |
Provider Name | Thibodeaux Albro & Touchet Therapy Group Llc |
---|---|
Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
Provider Identifiers | NPI Number: 1104973262 PECOS PAC ID: 7719081801 Enrollment ID: O20070329000354 |
News Archive
The U.S. Food and Drug Administration has been investigating reports that patients undergoing computed tomography (CT) brain perfusion scans were accidently exposed to excess radiation. The FDA found that when properly used, the CT scanners did not malfunction. Instead, it is likely that the improper use of the scanners resulted in these overdoses. However, the FDA has identified a series or promising steps to enhance the safety of these procedures. These steps could reduce the likelihood of radiation overexposure in the event of improper use of the CT scanners.
In a process akin to belling an infinitesimal cat, scientists have managed to tag a protein that regulates the neurotransmitter serotonin with tiny fluorescent beads, allowing them to track the movements of single molecules for the first time.
Medical device company Vertos Medical Inc. has announced the release of clinical study data demonstrating the long-term safety and efficacy of mild as well as its superior durability over epidural steroid injections for treating lumbar spinal stenosis.
Retinal gene therapy could prevent loss of vision in patients with choroideremia and other retinal diseases, show the results of a phase I/II study.
The Minimally Invasive Surgical Therapies (MIST) Consortium for Benign Prostatic Hyperplasia (BPH) has launched a new study to compare long-term benefits and risks of transurethral needle ablation (TUNA) and transurethral microwave thermotherapy (TUMT) to a regimen of the alpha-1 inhibitor alfuzosin and the 5-alpha reductase inhibitor finasteride.
› Verified 2 days ago
Provider Name | Acadiana Speech Therapy Sevices |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1740443894 PECOS PAC ID: 6709925894 Enrollment ID: O20091203000013 |
News Archive
The U.S. Food and Drug Administration has been investigating reports that patients undergoing computed tomography (CT) brain perfusion scans were accidently exposed to excess radiation. The FDA found that when properly used, the CT scanners did not malfunction. Instead, it is likely that the improper use of the scanners resulted in these overdoses. However, the FDA has identified a series or promising steps to enhance the safety of these procedures. These steps could reduce the likelihood of radiation overexposure in the event of improper use of the CT scanners.
In a process akin to belling an infinitesimal cat, scientists have managed to tag a protein that regulates the neurotransmitter serotonin with tiny fluorescent beads, allowing them to track the movements of single molecules for the first time.
Medical device company Vertos Medical Inc. has announced the release of clinical study data demonstrating the long-term safety and efficacy of mild as well as its superior durability over epidural steroid injections for treating lumbar spinal stenosis.
Retinal gene therapy could prevent loss of vision in patients with choroideremia and other retinal diseases, show the results of a phase I/II study.
The Minimally Invasive Surgical Therapies (MIST) Consortium for Benign Prostatic Hyperplasia (BPH) has launched a new study to compare long-term benefits and risks of transurethral needle ablation (TUNA) and transurethral microwave thermotherapy (TUMT) to a regimen of the alpha-1 inhibitor alfuzosin and the 5-alpha reductase inhibitor finasteride.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Mrs Kelli A Mahaffey, MS CCC-SLP Po Box 2206, Crowley, LA 70527-2206 Ph: (337) 788-2300 | Mrs Kelli A Mahaffey, MS CCC-SLP 225w 5th St, Crowley, LA 70526-4332 Ph: (337) 788-2300 |
News Archive
The U.S. Food and Drug Administration has been investigating reports that patients undergoing computed tomography (CT) brain perfusion scans were accidently exposed to excess radiation. The FDA found that when properly used, the CT scanners did not malfunction. Instead, it is likely that the improper use of the scanners resulted in these overdoses. However, the FDA has identified a series or promising steps to enhance the safety of these procedures. These steps could reduce the likelihood of radiation overexposure in the event of improper use of the CT scanners.
In a process akin to belling an infinitesimal cat, scientists have managed to tag a protein that regulates the neurotransmitter serotonin with tiny fluorescent beads, allowing them to track the movements of single molecules for the first time.
Medical device company Vertos Medical Inc. has announced the release of clinical study data demonstrating the long-term safety and efficacy of mild as well as its superior durability over epidural steroid injections for treating lumbar spinal stenosis.
Retinal gene therapy could prevent loss of vision in patients with choroideremia and other retinal diseases, show the results of a phase I/II study.
The Minimally Invasive Surgical Therapies (MIST) Consortium for Benign Prostatic Hyperplasia (BPH) has launched a new study to compare long-term benefits and risks of transurethral needle ablation (TUNA) and transurethral microwave thermotherapy (TUMT) to a regimen of the alpha-1 inhibitor alfuzosin and the 5-alpha reductase inhibitor finasteride.
› Verified 2 days ago
Regilyn W. Carter, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1455 Wright Ave, Suite A, Crowley, LA 70526 Phone: 337-788-1480 Fax: 337-788-0354 | |
Leah K. Langlinais, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 516 Southeast Court Circle, Crowley, LA 70527 Phone: 337-788-2300 Fax: 337-788-3219 | |
Abbie Preuett, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 225 W 5th St, Crowley, LA 70526 Phone: 337-788-2300 | |
Stacey Briolo, ST Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2122 N Parkerson Ave Ste A, Crowley, LA 70526 Phone: 985-855-1676 | |
Gwen Habetz, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2122 N Parkerson Ave, Crowley, LA 70526 Phone: 337-783-3668 | |
Margaret C. Bier, ST Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1455 Wright Ave, Suite A, Crowley, LA 70526 Phone: 337-788-1480 Fax: 337-788-0354 | |
Heather Bordelon, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 225 W 5th St, Crowley, LA 70526 Phone: 337-788-2300 Fax: 888-214-8710 |